ARCHIVES

FDA Spells Out Requirement For INDs For Cancer Drugs.

This article is from The Cancer Letter archive.

Vol. 28 No. 20 | May 17, 2002

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Recompetition Of Clinical Trials, Other Contracts, New BNCT Grants

October 28, 1988

GlaxoSmithKline Partners With MD Anderson, Fred Hutchinson

December 14, 2012

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

October 25, 1985

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

Final Issue of 1980

December 19, 1980

Clinical Trials Approved By NCI In November

December 28, 2001